Key Findings and Expert Recommendations in Gynecologic Malignancies: Independent 2023 Conference/Congress Coverage *

Get expert perspectives on emerging data in gynecologic cancers from key 2023 conferences with downloadable slides, podcasts, commentaries, and more.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options (CCO)

Supporters

This educational activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure, Genmab and Seagen.

AstraZeneca

Genmab

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Novocure

Seagen

*ProCE is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.